Junko Tsukada

1.0k total citations
44 papers, 842 citations indexed

About

Junko Tsukada is a scholar working on Social Psychology, Pulmonary and Respiratory Medicine and Endocrine and Autonomic Systems. According to data from OpenAlex, Junko Tsukada has authored 44 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Social Psychology, 27 papers in Pulmonary and Respiratory Medicine and 19 papers in Endocrine and Autonomic Systems. Recurrent topics in Junko Tsukada's work include Neuroendocrine regulation and behavior (29 papers), Electrolyte and hormonal disorders (27 papers) and Circadian rhythm and melatonin (18 papers). Junko Tsukada is often cited by papers focused on Neuroendocrine regulation and behavior (29 papers), Electrolyte and hormonal disorders (27 papers) and Circadian rhythm and melatonin (18 papers). Junko Tsukada collaborates with scholars based in Japan and Norway. Junko Tsukada's co-authors include Atsuo Tahara, Yuichi Tomura, Takeyuki Yatsu, Wataru Uchida, Koh‐ichi Wada, Toshiyuki Kusayama, Akihiro Tanaka, Noe Ishii, Masayuki Shibasaki and Masahiro Takanashi and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Junko Tsukada

44 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junko Tsukada Japan 16 437 399 334 160 158 44 842
Yuichi Tomura Japan 18 467 1.1× 395 1.0× 388 1.2× 162 1.0× 195 1.2× 59 1.0k
Koh‐ichi Wada Japan 14 415 0.9× 362 0.9× 285 0.9× 144 0.9× 142 0.9× 32 686
Toshiyuki Onogawa Japan 8 760 1.7× 513 1.3× 537 1.6× 146 0.9× 149 0.9× 13 1.1k
Toshiyuki Kusayama Japan 12 316 0.7× 322 0.8× 245 0.7× 141 0.9× 112 0.7× 30 589
C. Serradeil‐Le Gal France 13 354 0.8× 467 1.2× 414 1.2× 211 1.3× 91 0.6× 20 962
Noe Ishii Japan 13 179 0.4× 208 0.5× 170 0.5× 101 0.6× 72 0.5× 26 449
Brigitte Pouzet France 8 192 0.4× 221 0.6× 185 0.6× 212 1.3× 37 0.2× 11 521
Tetsumi Hosokawa Japan 7 218 0.5× 179 0.4× 218 0.7× 51 0.3× 79 0.5× 16 496
J. H. Cort Czechia 18 271 0.6× 213 0.5× 150 0.4× 72 0.5× 36 0.2× 38 677
Pascale Bardoux France 9 387 0.9× 146 0.4× 346 1.0× 48 0.3× 57 0.4× 9 645

Countries citing papers authored by Junko Tsukada

Since Specialization
Citations

This map shows the geographic impact of Junko Tsukada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Tsukada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Tsukada more than expected).

Fields of papers citing papers by Junko Tsukada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Tsukada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Tsukada. The network helps show where Junko Tsukada may publish in the future.

Co-authorship network of co-authors of Junko Tsukada

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Tsukada. A scholar is included among the top collaborators of Junko Tsukada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Tsukada. Junko Tsukada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akizawa, Tadao, et al.. (2016). Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial. Therapeutic Apheresis and Dialysis. 20(6). 588–597. 8 indexed citations
2.
Tahara, Atsuo, Junko Tsukada, Yuichi Tomura, Takeyuki Yatsu, & Masayuki Shibasaki. (2012). Effects of High Glucose on AVP-Induced Hyperplasia, Hypertrophy, and Type IV Collagen Synthesis in Cultured Rat Mesangial Cells. Endocrine Research. 37(4). 216–227. 12 indexed citations
3.
Tahara, Atsuo, Junko Tsukada, Yuichi Tomura, Takeyuki Yatsu, & Masayuki Shibasaki. (2008). Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells. Pharmacological Research. 57(2). 142–150. 26 indexed citations
4.
Tahara, Atsuo, Junko Tsukada, Yuichi Tomura, et al.. (2006). Binding and Signal Transduction Characteristics of the Nonpeptide Vasopressin V<sub>1A</sub> Receptor-Selective Antagonist YM218 in Cultured Rat Mesangial Cells. Pharmacology. 78(2). 81–90. 4 indexed citations
5.
Shimada, Yoshiaki, Nobuaki Taniguchi, Akira Matsuhisa, et al.. (2005). Preparation of Highly Potent and Selective Non-Peptide Antagonists of the Arginine Vasopressin V1A Receptor by Introduction of a 2-Ethyl-1H-1-imidazolyl Group. Chemical and Pharmaceutical Bulletin. 53(7). 764–769. 9 indexed citations
6.
Tahara, Atsuo, Junko Tsukada, Yuichi Tomura, et al.. (2004). Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors. Pharmacological Research. 51(3). 275–281. 15 indexed citations
7.
Fukuda, Izumi, Naomi Hizuka, Yukiko Ishikawa, et al.. (2004). Serum adiponectin levels in adult growth hormone deficiency and acromegaly. Growth Hormone & IGF Research. 14(6). 449–454. 22 indexed citations
8.
Tahara, Atsuo, Junko Tsukada, Yuichi Tomura, et al.. (2003). Alterations of Renal Vasopressin V<sub>1A</sub> and V<sub>2</sub> Receptors in Spontaneously Hypertensive Rats. Pharmacology. 67(2). 106–112. 11 indexed citations
9.
Tsukada, Junko, Atsuo Tahara, Yuichi Tomura, et al.. (2002). Pharmacological characterization of YM471, a novel potent vasopressin V1A and V2 receptor antagonist. European Journal of Pharmacology. 446(1-3). 129–138. 13 indexed citations
10.
Tahara, Atsuo, Junko Tsukada, Yuichi Tomura, et al.. (2002). Effect of YM471, a nonpeptide AVP receptor antagonist, on human coronary artery smooth muscle cells. Peptides. 23(10). 1809–1816. 5 indexed citations
11.
Wada, Koh‐ichi, Atsuo Tahara, Yukinori Arai, et al.. (2002). Effect of the vasopressin receptor antagonist conivaptan in rats with heart failure following myocardial infarction. European Journal of Pharmacology. 450(2). 169–177. 22 indexed citations
12.
Tsukada, Junko, Atsuo Tahara, Yuichi Tomura, et al.. (2001). Effects of YM471, a nonpeptide AVP V1A and V2 receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells. British Journal of Pharmacology. 133(5). 746–754. 10 indexed citations
13.
Tahara, Atsuo, Masayuki Saito, Toru Sugimoto, et al.. (1999). AVP-induced mitogenic responses of Chinese hamster ovary cells expressing human V 1A or V 1B receptors. Pflügers Archiv - European Journal of Physiology. 437(2). 219–226. 9 indexed citations
14.
Yatsu, Takeyuki, Yuichi Tomura, Atsuo Tahara, et al.. (1999). Pharmacology of conivaptan hydrochloride (YM087), a novel vasopressin V1A/V2 receptor antagonist. Folia Pharmacologica Japonica. 114(supplement). 113–117. 3 indexed citations
15.
Tahara, Atsuo, Masayuki Saito, Junko Tsukada, et al.. (1999). Vasopressin increases vascular endothelial growth factor secretion from human vascular smooth muscle cells. European Journal of Pharmacology. 368(1). 89–94. 21 indexed citations
16.
Tahara, Atsuo, Junko Tsukada, Noe Ishii, et al.. (1999). Comparison of vasopressin binding sites in human uterine and vascular smooth muscle cells. European Journal of Pharmacology. 378(1). 137–142. 5 indexed citations
17.
Tahara, Atsuo, Masayuki Saito, Toru Sugimoto, et al.. (1998). Pharmacological characterization of the human vasopressin receptor subtypes stably expressed in Chinese hamster ovary cells. British Journal of Pharmacology. 125(7). 1463–1470. 51 indexed citations
18.
Tahara, Atsuo, Yuichi Tomura, Koh‐ichi Wada, et al.. (1998). Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte. Cardiovascular Research. 38(1). 198–205. 57 indexed citations
19.
Tahara, Atsuo, Masayuki Saito, Toru Sugimoto, et al.. (1997). Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist. Naunyn-Schmiedeberg s Archives of Pharmacology. 357(1). 63–69. 44 indexed citations
20.
Yatsu, Takeyuki, Yuichi Tomura, Atsuo Tahara, et al.. (1997). Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs. European Journal of Pharmacology. 321(2). 225–230. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuichi Tomura Breakdown of academic impact, for papers by Koh‐ichi Wada Breakdown of academic impact, for papers by Toshiyuki Onogawa Breakdown of academic impact, for papers by Toshiyuki Kusayama Breakdown of academic impact, for papers by C. Serradeil‐Le Gal Breakdown of academic impact, for papers by Noe Ishii Breakdown of academic impact, for papers by Brigitte Pouzet Breakdown of academic impact, for papers by Tetsumi Hosokawa Breakdown of academic impact, for papers by J. H. Cort Breakdown of academic impact, for papers by Pascale Bardoux
Rankless by CCL
2026